All News

AstrasZeneca's antipsychotic in combination with lithium or divalproex is okayed for bipolar maintenance.

Winn-Dixie supermarket pharmacy is making it easier for customers to use their health savings account and flexible spending account cards.

Bayer will remove remaining supplies of Trasylol from market following the publication of negative study results.

Because Scientific Laboratories' products are not approved or have not met good manufacturing practices, FDA is barring them from being sold.

Consumers Union is urging the FDA to move ahead with requiring TV ads for Rx drugs to include a toll free number and a Web site address to report serious side effects from presciption drugs.

Faced with increased costs of supplying uncontaminated heparin, APP Pharmaceuticals adjusts the cost of its product.

A new report from Avalere Health has found that many drugs were dropped from CMS' 2008 Part D formulary files.

NACDS applauded action by the House Judiciary Committee to address excessive fees imposed by credit card companies for retail transactions.

Aetna reports that its MTM programs have worked due to pharmacist interventions

A new Medco study of insured patients show that more people are taking drugs for chronic diseases.

NACDS testifies on impact of Medicare and Medicaid regulations on pharmacies.

Two supermarket chains follow in Wal-Mart's footsteps by offering 90-day supplies of generics at $10.

Several lots of Doxil, Procrit, and Remicade have been stolen, prompting the manufacturers to issue a voluntary withdrawal of the lots affected.

Kroger and Wal-Mart recently announced enhancments to their in store pharmaices $4 generic drug programs.

Novalar Pharmaceuticals granted approval for first dental anesthesia reversal agent, phentolamine mesylate (OraVerse).

Warner Chilcott and Leo Pharma announc the FDA approval of a new combination suspension for psoriasis of the scalp.

A new Pennsylvania law sets up a voluntary drug repository program for cancer patients.

A new study funded by GlaxoSmithKline found that Type 2 diabetics who have to shell out higher copays are more likely to not take their drugs as indicated.

Recombinant coagulation Factor VIIa is reformulated to allow for room temperature storage for up to two years.

Several healthcare groups are planning to stage demonstrations on May 30 over FDA's decision not to approve Provenge for prostate cancer.

Walgreens Health Inititaitves reports that highly managed plans experienced a decline in prescription drug cost trend.

FDA is holding a meeting, launching a pilot, and releasing a concept paper about drug names next month.

Oklahoma pharmacies can now renew their narcotic registration electronically.

In face of new proposals to ban the sale of cigarettes in drugstores, more retail chains are opting to stop selling these products.

A market research firm forecasts that more drug-eluting stents are on the way, which will bring down the costs of these devices.

Wisconsin Pharmacy Collaborative launches pilot medication therapy management program.

Drug errors and other lapses in patient care sends a North Carolina hospital into a tailspin

The Centers for Medicare & Medicaid Services has added new critiera hospitals must meet in order to get optimal reimbursement